WILMINGTON, Del. & OSAKA, Japan –(BUSINESS WIRE)–Apr. 28, 2022– Incyte (NASDAQ:INCY) and Maruho Co., Ltd. today announced that the companies have entered into a Strategic Alliance Agreement for the development, manufacturing and exclusive commercialization of ruxolitinib cream, a novel cream